FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoshitsugu Kojima

Research Profile

Living Beings

Chemicals & Drugs

Physiology

Cellular Immunity

Procedures

Enzyme-Linked Immunosorbent Assay

Anatomy

Genes & Molecular Sequences

Genes, env

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
Shinji Yoshizaki; Naoki Yamamoto; Yoshitsugu Kojima; Asami Kondo; Mayuko Nishi; Akihide Ryo
Vaccination with Human Induced Pluripotent Stem Cells Creates an Antigen-Specific Immune Response Against HIV-1 gp160.
Yoshitsugu Kojima; Akihide Ryo
Pinning down viral proteins: a new prototype for virus-host cell interaction.
Seiichi Kanzaki; Akira Yamaguchi; Kayoko Yamaguchi; Yoshitsugu Kojima; Kyoko Suzuki; Noriko Koumitsu; Yoji Nagashima; Kiyotaka Nagahama; Michiko Ehara; Yoshio Hirayasu; Akihide Ryo; Ichiro Aoki; Shoji Yamanaka
Thymic alterations in GM2 gangliosidoses model mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoshitsugu Kojima (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Shinji Yoshizaki; Naoki Yamamoto; Yoshitsugu Kojima; Asami Kondo; Mayuko Nishi; Akihide Ryo
Vaccination with Human Induced Pluripotent Stem Cells Creates an Antigen-Specific Immune Response Against HIV-1 gp160.
Frontiers in microbiology 2011;2():27.
2010: Yoshitsugu Kojima; Akihide Ryo
Pinning down viral proteins: a new prototype for virus-host cell interaction.
Frontiers in microbiology 2010;1():107.
2010: Seiichi Kanzaki; Akira Yamaguchi; Kayoko Yamaguchi; Yoshitsugu Kojima; Kyoko Suzuki; Noriko Koumitsu; Yoji Nagashima; Kiyotaka Nagahama; Michiko Ehara; Yoshio Hirayasu; Akihide Ryo; Ichiro Aoki; Shoji Yamanaka
Thymic alterations in GM2 gangliosidoses model mice.
PloS one 2010;5(8):.
2007: Yoshitsugu Kojima; Nao Jounai; Fumihiko Takeshita; Masatoshi Nakazawa; Kentaro Okuda; Setsuko Watabe; Ke-Qin Xin; Kenji Okuda
The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection.
Vaccine 2007;25(3):438-45.
2006: Ke-Qin Xin; Hiroaki Mizukami; Masashi Urabe; Yoshihiko Toda; Kaori Shinoda; Atsushi Yoshida; Kenji Oomura; Yoshitsugu Kojima; Motohide Ichino; Dennis M Klinman; Keiya Ozawa; Kenji Okuda
Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.
Journal of virology 2006;80(24):11899-910.
2006: Kaori Shinoda; Ke-Qin Xin; Yoshitsugu Kojima; Sukumar Saha; Kentaro Okuda; Kenji Okuda
Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
Clinical immunology (Orlando, Fla.) 2006;119(1):32-7.
2005: Fumihiko Takeshita; Ken J Ishii; Kouji Kobiyama; Yoshitsugu Kojima; Cevayir Coban; Shin Sasaki; Norihisa Ishii; Dennis M Klinman; Kenji Okuda; Shizuo Akira; Koichi Suzuki
TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF.
European journal of immunology 2005;35(8):2477-85.
2005: Tatsuya Hisajima; Yoshitsugu Kojima; Akira Yamaguchi; Richard C Goris; Kengo Funakoshi
Morphological analysis of the relation between immunoglobulin A production in the small intestine and the enteric nervous system.
Neuroscience letters 2005;381(3):242-6.
2005: Yan Shen; Motohide Ichino; Masatoshi Nakazawa; Takashi Ikejima; Yoshitsugu Kojima; Kenji Okuda; Mutsuhiko Minami
Therapeutic effect of CpG-enriched plasmid administration on the tight-skin mouse model of scleroderma.
Journal of autoimmunity 2005;24(3):183-90.
2004: Kaori Shinoda; Ke-Qin Xin; Nao Jounai; Yoshitsugu Kojima; Yuichi Tamura; Eiichi Okada; Susumu Kawamoto; Kenji Okuda; Dennis M Klinman; Kenji Okuda
Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
Vaccine 2004;22(27-28):3676-90.
2003: Nao Jounai; Kenji Okuda; Yoshitsugu Kojima; Yoshihiko Toda; Kenji Hamajima; Kenji Ohba; Dennis M Klinman; Ke-Qin Xin
Contribution of the rev gene to the immunogenicity of DNA vaccines targeting the envelope glycoprotein of HIV.
The journal of gene medicine 2003;5(7):609-17.
2003: Ke-Qin Xin; Yuka Hoshino; Yoshihiko Toda; Shizunobu Igimi; Yoshitsugu Kojima; Nao Jounai; Kenji Ohba; Akira Kushiro; Mayumi Kiwaki; Kenji Hamajima; Dennis M Klinman; Kenji Okuda
Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env.
Blood 2003;102(1):223-8.
2003: Ke-Qin Xin; Takaaki Ooki; Nao Jounai; Hiroaki Mizukami; Kenji Hamajima; Yoshitsugu Kojima; Kenji Ohba; Yoshihiko Toda; Syu-Ichi Hirai; Dennis M Klinman; Keiya Ozawa; Kenji Okuda
A DNA vaccine containing inverted terminal repeats from adeno-associated virus increases immunity to HIV.
The journal of gene medicine 2003;5(5):438-45.
2002: Ke-Qin Xin; Takaaki Ooki; Hiroaki Mizukami; Kenji Hamajima; Koji Okudela; Kumiko Hashimoto; Yoshitsugu Kojima; Nao Jounai; Yasuko Kumamoto; Shin Sasaki; Dennis M Klinman; Keiya Ozawa; Kenji Okuda
Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses.
Human gene therapy 2002;13(13):1571-81.
2002: Yoshitsugu Kojima; Ke-Qin Xin; Takaaki Ooki; Kenji Hamajima; Tomohiro Oikawa; Kaori Shinoda; Tomomi Ozaki; Yuka Hoshino; Nao Jounai; Masatoshi Nakazawa; Dennis M Klinman; Kenji Okuda
Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine.
Vaccine 2002;20(23-24):2857-65.
2001: K Tadokoro; Y Koizumi; Y Miyagi; Yoshitsugu Kojima; S Kawamoto; Kenji Hamajima; Kenji Okuda; S Tanaka; K Onari; Britta Wahren; I Aoki; K Okuda
Rapid and wide-reaching delivery of HIV-1 env DNA vaccine by intranasal administration.
Viral immunology 2001;14(2):159-67.